Therapeutic cancer vaccines aim to treat existing cancer by activating the adaptive immune system and triggering T-lymphocyte responses, including the production of antigen-specific CD8+ cytotoxic T lymphocytes (CTLs) that can recognize and kill cancer cells. Here, CD8A is linked to cancer.